Skip to main content
. Author manuscript; available in PMC: 2023 Jan 20.
Published in final edited form as: J Neural Transm (Vienna). 2022 Oct 28;129(12):1487–1511. doi: 10.1007/s00702-022-02550-0

Figure 1.

Figure 1.

The clinical groups selected for this study along with their associated speech motor subtype, presumed neurological deficit and pathophysiological mechanism, and example articulatory patterns based on the Darley, Aronson, and Brown (DAB) model (ALS = amyotrophic lateral sclerosis; PA = progressive ataxia; PD = Parkinson’s disease; nfPPA+PAOS = the nonfluent variant of primary progressive aphasia and progressive apraxia of speech).